Omni Bio Pharmaceutical, Inc. ("Omni Bio") (OTC OMBP.OB) announced that U.S. Patent No. 8,071,551, entitled "METHODS AND COMPOSITIONS FOR TREATING DIABETES," was issued by the United States Patent and Trademark Office on December 6, 2011 (the "Diabetes Patent"). The Diabetes Patent expires in May 2022. The Diabetes Patent is the most recently issued patent that Omni Bio licenses under agreements with the University of Colorado Denver and a private company...
View the original article here
This post was made using the
Auto Blogging Software from
WebMagnates.org This line will not appear when posts are made after activating the software to full version.
No comments:
Post a Comment